Glicerina

Quick links to important sections

Glicerina

Method of action: Laxative

Treatment option: Sore Throat, Constipation

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Glicerina

This section establishes the identity, classification, and general purpose of Glicerina, strictly adhering to the exclusion of details regarding dosage, specific treatments, safety, or commerce.

Property Description
Active ingredient Glycerol (1,2,3-propanetriol)
Form Suppository, Solution, Cream, Ointment
Pharmacological class Hyperosmotic Agent
General purpose Aiding elimination and skin hydration
Origin Natural (fats/oils) or Synthetic

What Type of Medicinal Substance is Glicerina?

The medicinal substance known as Glicerina refers to pharmaceutical preparations that utilize Glycerol as the active compound, a substance with the chemical designation 1,2,3-propanetriol. Glycerol is formally classified in pharmacology as a Hyperosmotic Agent, a class defined by its ability to influence fluid balance across biological membranes. This classification reflects that the medicine works by altering fluid movement to achieve its effects. Chemically, Glycerol is characterized as a polyol and a trihydroxy alcohol. Glycerol can be derived from natural sources, such as the saponification of plant or animal fats, or it may be manufactured synthetically. Its role as a single-ingredient product differentiates it from combination remedies, although it is frequently used as a pharmaceutical vehicle or solvent.

Glicerina: Available Forms and General Application

Glicerina is a versatile compound available in multiple dosage forms, including the suppository, solution (for enema or oral use), and topical cream or ointment. This variety allows the substance to exert its general purpose through two primary, yet distinct, actions. Rectally administered forms function by a localized osmotic water attraction, which helps to hydrate and soften contents within the lower bowel. Conversely, when formulated as a topical product, its primary therapeutic strength lies in its humectant quality, meaning it attracts and retains external moisture to the skin surface. This function helps to improve the skin’s hydration and overall barrier integrity, offering a benefit in managing minor skin dryness.

What side effects are possible with Glicerina?

Possible side effects and safety information

The safety profile for Glicerina (Glycerol) is primarily defined by local effects consistent with its action as a hyperosmotic agent. Regulatory documents classify the most frequent adverse events into specific system-organ classes.


Documented Adverse Reactions

The majority of side effects are localized and categorized within Gastrointestinal Disorders for rectal forms and Skin and Subcutaneous Tissue Disorders for topical applications.

Commonly documented adverse events, particularly with rectal use, include local rectal irritation, cramping pain, abdominal discomfort, and tenesmus (a persistent feeling of needing to pass stool). Systemic effects, such as headache, nausea, and vomiting, are also listed but typically associated with higher systemic absorption or oral/intravenous use, and are often classified as of frequency not defined in specific labels.


Serious Safety Considerations and Regulatory Constraints

Official labeling addresses specific, more serious safety concerns. These include the potential for severe allergic reactions, and the risk of severe dehydration and electrolyte imbalance associated with excessive or prolonged systemic absorption, or misuse. Furthermore, rectal bleeding is documented as a sign that necessitates discontinuing use and seeking medical assessment, as per regulatory guidance.

Time-Related Patterns: The risk of developing laxative dependence or a loss of normal bowel function is explicitly associated with the prolonged or frequent use of Glicerina suppositories or enemas.

Key Safety Restrictions: The medicine is formally contraindicated in the presence of gastrointestinal obstruction or severe fecal impaction (for rectal forms), and in individuals with a known hypersensitivity to the active ingredient or excipients, as these conditions increase the risk of serious complications.

Overdose and Emergency Response

An overdose of Glicerina (Glycerol) is characterized by its systemic effects as a hyperosmotic agent, primarily concerning fluid balance and metabolism. Regulatory documents describe overdose presentations that include gastrointestinal symptoms such as nausea and vomiting. More significant exposure can lead to central nervous system effects, presenting as headache, confusion, and somnolence. The official profile highlights the risk of severe metabolic disturbances, including a hyperosmolar state and dangerous hypoglycemia (low blood sugar), which is a particular concern in young children.

When overdose is suspected, immediate medical attention must be sought. Official guidance states that emergency services should be contacted if the affected individual becomes drowsy or confused. Management is defined as symptomatic and supportive treatment, involving necessary steps such as fluid replacement, correction of electrolyte imbalances, and urgent blood glucose stabilization. No specific antidote is known. Patients with pre-existing conditions, such as renal impairment, or young children are noted to be at increased risk of severe complications from overexposure.

Therapeutic Uses of Glicerina

Main Therapeutic Uses and Benefits

The main therapeutic domains of Glicerina (Glycerin/Glycerol) are diverse, covering several key symptom clusters. This substance is applied across domains where additional symptomatic support is needed, relevant in contexts involving heightened systemic burden. Common applications include: the substance is relevant for easing the symptoms related to physical discomfort of sore throats; is commonly used to help with symptoms related to inflammatory or irritative states of the skin, such as rough or chapped skin; and may assist with maintaining functional stability of the digestive system, applied in addressing temporary constipation.

Glicerina supports the patient during difficult episodes by easing distress. Its application is relevant in clinical settings that involve acute or unstable symptom patterns. It is considered relevant for easing symptoms that create noticeable physiological strain. This use provides supportive relief when symptoms interfere with routine activities. This broad application contributes to improved comfort during periods of heightened symptoms across various conditions presenting with systemic or localized discomfort.


Quick Fact: Supports Symptomatic Management for Sore Throats and Temporary Constipation

Eligibility and Restrictions for Use

The official regulatory classification for Glicerina (Glycerol) defines strict population eligibility based on a patient's clinical status and age, as documented in government labeling.

Absolute Contraindications

Use is officially prohibited for individuals with a known hypersensitivity to the active ingredient or any product components. The medicine must not be used in the presence of acute clinical signs, including abdominal pain, nausea, or vomiting, as these may indicate a more serious condition. Patients with a diagnosis of intestinal obstruction or fecal impaction are formally excluded from use.

Age-Based and Conditional Eligibility

Glicerina is generally permitted for adults and children 6 years and over. Use in children from 2 to under 6 years is allowed only with an appropriate child-strength product. For children under 2 years, official labeling mandates that a health professional must be consulted before administration.

Use is formally restricted to a maximum of one week; consultation with a doctor is required if the product is needed longer or if the patient has experienced a sudden change in bowel habits lasting over two weeks.

Regulatory labeling advises that individuals who are pregnant or breastfeeding must ask a health professional before using the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory documents for Glicerina define the product's interaction profile through limitations on co-administration and specific metabolic warnings, rather than through complex pharmacokinetic (PK) pathways.


Pharmacodynamic and Metabolic Constraints

Glicerina, as a hyperosmotic agent, carries a risk of additive effects when co-administered with substances that similarly affect fluid balance. This includes Diuretics and other laxative products, where the combined effects could potentially lead to electrolyte changes or increased laxative action. A critical, population-specific note in official labeling concerns diabetic patients: the metabolic conversion of glycerol into glucose may interfere with blood sugar control, requiring caution.


Pharmacokinetic and Usage Restrictions

Regulatory documentation states the absence of known interactions involving major metabolic enzymes (e.g., CYP) or drug transporters, consistent with the minimal systemic absorption of the product. The most critical constraint is the formal contraindication of the laxative form in the presence of intestinal obstruction or blockage, a mandatory restriction explicitly listed in official prescribing information. No specific mandatory time-separation requirements are formally documented for Glicerina interactions.

Mechanism of Action

How Glicerina Works

Glicerina (Glycerin) operates through a distinct physicochemical mechanism centered on osmosis. Upon localized application within the rectal lumen, Glicerina establishes a significant hyperosmotic gradient due to its low absorption rate. This differential concentration drives the passive movement of water from the surrounding intestinal tissues and circulation into the lumen. This fluid recruitment is the primary action, resulting in a substantial increase in the volume and an alteration of the consistency of the fecal mass .

This physical expansion, in conjunction with localized physicochemical interaction on the rectal mucosa, engages afferent sensory nerve endings. This engagement initiates the defecation reflex cascade, which represents a specific type of neuro-muscular pathway modulation. The process modifies downstream efferent signaling, thereby regulating the neuro-muscular activity in the distal colon and rectum.

Dosage and Administration Information

The usage of Glicerina (Glycerol) is strictly defined by regulatory guidelines based on the approved route of administration and dosage form. Official routes include rectal administration via suppository or liquid enema, oral administration as a solution, and topical application as a cream or liquid.


Official Dosing and Frequency Patterns

Standard adult rectal dosing involves a single-use suppository in the range of 2 g to 3 g or a liquid enema of 5.4 g to 5.6 g, administered once daily as needed. Oral solution for demulcent use is typically taken in 5 to 10 mL doses four hourly as required. Topical products are applied directly to the skin, with frequency guidelines allowing up to six times daily.

For specific populations, official guidelines detail pediatric rectal regimens: children 2 to <6 years use 1 g to 1.2 g once daily, while children 6 years and older use the adult range.


Administration Conditions and Duration

Rectal forms are designated for short-term use only, with instructions typically advising against use for longer than one week without professional guidance. Procedurally, the suppository should be retained for approximately 15 minutes; it acts without requiring complete melting. Where prescribed, the oral solution may be mixed with fruit juice or poured over cracked ice to improve palatability. Highly specialized oral or intravenous hyperosmotic dosing is typically administered intermittently based on body weight, such as 1 to 2 g/kg initially, to manage fluid dynamics.

Recent Clinical Evidence

Glicerina: Recent Clinical Evidence

Glycerin (also known as glycerol) is a widely used ingredient in pharmaceutical and cosmetic preparations, with its clinical evidence focusing primarily on its action as an osmotic agent and a humectant.

Uses Supported by Clinical Evidence

Clinical research generally supports the use of glycerin in two main therapeutic areas: topical skin care and the management of constipation.

1. For Skin Conditions (Topical Use)

Multiple randomized controlled trials (RCTs) and systematic reviews indicate that topical glycerin preparations can contribute to the management of dry skin conditions such as xerosis, eczema (atopic dermatitis), and psoriasis. Studies suggest that glycerin is an effective humectant that increases hydration in the skin's outermost layer (stratum corneum). Research has explored its role in:

  • Skin Barrier Function: Evidence suggests glycerin may help accelerate the repair of the skin barrier, potentially reducing water loss.
  • Wound Healing: Some clinical findings propose that glycerin-containing dressings may promote a moist environment conducive to wound healing and may exhibit bacteriostatic properties in high concentrations.

2. For Constipation (Rectal Use)

As a hyperosmotic laxative, glycerin is used via rectal administration (suppository or enema). Controlled clinical studies show it is an effective agent for the short-term relief of occasional constipation in both adults and children over the age of two. Its effect involves drawing water into the colon, which softens the stool and promotes a bowel movement.

Emerging Research

Research is ongoing to evaluate other potential uses of oral glycerin formulations, including as an agent to help sustain hydration during athletic activity, although current evidence does not offer conclusive support for improving athletic performance. Other areas of study, such as its use in reducing neurological sequelae in bacterial meningitis, are considered inconclusive or possibly ineffective based on available trial data.

Frequently Asked Questions (FAQ)

Common questions about Glicerina (FAQ)


Q: Is Glicerina considered a prescription drug or is it available over the counter?

Most common forms of Glicerina (Glycerin), such as the rectal suppositories and topical creams, are categorized by regulatory bodies as Over-The-Counter (OTC) products. This means they are generally available without a prescription. Specialized, highly concentrated oral or intravenous formulations may be classified differently.


Q: Is Glicerina suitable for people with diabetes?

Official labeling advises caution. Regulatory documents indicate that the body can metabolize Glycerol into glucose, which may interfere with blood sugar control. Individuals with diabetes may need professional consultation to determine appropriate use.


Q: Can Glicerina cause digestive upset?

Yes, common documented adverse events for rectal use include gastrointestinal effects, such as cramping pain and abdominal discomfort. Systemic effects like nausea and vomiting are also noted in official product information, typically associated with higher systemic absorption.


Q: What common over-the-counter products might interact with Glicerina?

Official regulatory information identifies a risk of additive effects when Glicerina is used alongside certain other products. These include diuretics and other laxative products, as the combined use may affect the body's fluid balance.


Q: How is Glicerina processed by the body?

When Glicerina (Glycerol) is absorbed by the body, it is distributed and primarily serves as a precursor for glucose synthesis in the liver. A small amount, ranging from 7% to 14%, is reported to be excreted unchanged in the urine.


Q: Does Glicerina have a long-term effect on the body if used regularly?

Regulatory guidance notes that using the laxative forms for an extended period carries a risk of developing laxative dependence or a loss of normal bowel function. Rectal forms are formally restricted to a maximum of one week of use without consulting a professional.


Q: What is the difference between Glicerina and Glycerin?

The terms 'Glicerina' and 'Glycerin' refer to the same active substance, which is chemically known as Glycerol (1,2,3-propanetriol). Both terms are used in various regulatory and official documents globally, reflecting the compound's international recognition.


Q: Are there different brand names for the medicine Glicerina?

Yes, the active ingredient Glycerin is widely used in pharmaceutical and cosmetic preparations and is available under many different brand names. This applies to products intended for both rectal use and topical applications.


Q: Is Glicerina safe for use by older adults?

Official labeling provides general instructions for use by adults and does not list a specific contraindication based on advanced age. Use should follow the general guidance for the adult population.


Q: Is it common to feel a slight burning sensation when using Glicerina?

Yes, a burning sensation is listed in official regulatory labeling as a common documented adverse reaction. This local effect often occurs alongside rectal irritation or discomfort.


Q: How quickly does Glicerina usually start to work?

For rectal administration (suppositories or enemas), the medicine generally produces a rapid effect. Official product information indicates that an action typically occurs within 15 minutes and usually no longer than one hour.


Q: Is Glicerina habit-forming or addictive?

Regulatory documents do not use the term 'addictive.' However, they explicitly warn that frequent or prolonged use of the laxative forms carries a definite risk of developing laxative dependence, which is a functional reliance.


Q: Is it possible to be allergic to Glicerina?

Yes, hypersensitivity to the active ingredient or any component of the product is listed as a formal contraindication. Signs of an allergic reaction, such as a rash, hives, or swelling, are noted as potential adverse events.


Q: Are the side effects of Glicerina permanent?

The most commonly documented side effects are localized and temporary in nature. There are no regulatory statements suggesting that typical adverse reactions are permanent.


Q: Does Glicerina make you tired or dizzy?

Dizziness is a documented adverse effect associated with excessive systemic absorption, rapid consumption, or high concentrations. However, it is not listed as a common expected side effect of labeled rectal use.


Q: Can Glicerina be used for preventative measures?

Official regulatory guidance specifies that Glicerina is indicated for the relief of occasional constipation. It is not intended for use in treating or preventing chronic (long-term) conditions.


Q: Is it normal if Glicerina doesn't work for me the first time I use it?

The product is generally expected to work rapidly after insertion; official guidance recommends seeking medical advice if the product fails to produce an action within an hour.


Q: Is Glicerina considered safe for long-term repeated use?

No; regulatory documents formally restrict the use of the rectal forms to a maximum of one week without consulting a professional. This restriction is due to the documented risk of functional dependence or a loss of normal bowel function.


Q: Is the term 'Glicerina' used internationally or just locally?

The substance is known internationally, with Glycerin and Glycerol being the active ingredient names used across different regulatory labels and health bodies worldwide, including those in Europe and the US.


How should Glicerina be stored and disposed of?

How to Store and Dispose of Glicerina?

Glicerina (Glycerin/Glycerol) must be stored properly to maintain its stability. Since it is a hygroscopic material, you must keep the container tightly closed and store it in a cool, dry, and well-ventilated area to protect it from moisture. It should be kept away from excessive heat and stored out of the reach of children. The bulk product generally has a long shelf life, but any finished medicinal products containing Glicerina may have specific in-use stability periods after opening or mixing, which must be strictly followed.

For disposal, do not pour large amounts down the drain or flush. All waste, including containers and any unused product, must be disposed of in accordance with local, state, and federal regulations to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Glicerina found in:

A-Z Index: